April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
PASCAL Retinal Photocoagulation: Review of Parameters Applied in 1,241 Treatments
Author Affiliations & Notes
  • P. Lanzetta
    Dept of Ophthalmology,
    University of Udine, Udine, Italy
  • D. Veritti
    Dept of Ophthalmology,
    University of Udine, Udine, Italy
  • I. Zucchiatti
    Dept of Ophthalmology,
    University of Udine, Udine, Italy
  • C. Savorgnani
    Dept of Ophthalmology,
    University of Udine, Udine, Italy
  • D. Drigo
    Istitute of Hygiene and Epidemiology, DPMSC,
    University of Udine, Udine, Italy
  • F. Bandello
    Dept of Ophthalmology,
    University of Udine, Udine, Italy
  • Footnotes
    Commercial Relationships  P. Lanzetta, Iridex Co, P; Neovista Inc, C; Novartis Pharma AG, C; Allergan, R; Novartis Pharma AG, R; QLT Inc, R; Optimedica Co, R; D. Veritti, None; I. Zucchiatti, None; C. Savorgnani, None; D. Drigo, None; F. Bandello, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 213. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Lanzetta, D. Veritti, I. Zucchiatti, C. Savorgnani, D. Drigo, F. Bandello; PASCAL Retinal Photocoagulation: Review of Parameters Applied in 1,241 Treatments. Invest. Ophthalmol. Vis. Sci. 2009;50(13):213.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To report laser parameters used for the PASCAL® photocoagulation system with short pulse duration (20 msec) in patients treated at our institution for different retinal conditions. Perioperative complications type and incidence are also reported.

Methods: : We conducted a retrospective chart review of 752 eyes who underwent laser treatment using the PASCAL® photocoagulation system from December 2006 to November 2008. A total of 1,241 interventions applied with a wide field (Quadraspheric) or three mirror lens were divided into three groups - group A, focal or modified grid macular laser for diabetic macular edema; group B, panretinal photocoagulation for proliferative diabetic retinopathy; group C, retinopexy for retinal tears and holes. Retinal whitening was the desired endpoint during irradiation. Descriptive statystical analysis was performed for laser settings including power, exposure time, spot size, number of spots, number of treatments/eye. The gaussianity of each distribution was tested with Shapiro-Wilk test.

Results: : Results are synthetized in Table 1. Most frequently used patterns were single spot (89% of cases) in group A, 5x5 box with 0.5 spot spacing (72%) in group B, and 2x2 box with 0.5 spot spacing (78%) in group C. Distributions of all variables analysed are non-normal and asymmetrical. No complications was encountered in group A and C. In group B, three cases of retinal haemorrhage secondary to a micro-explosion and two cases of choroidal detachment were reported.

Conclusions: : Retinal photocoagulation with short duration is clinically feasible without significant complications. Powers used are higher than usually applied with longer pulses (100-200 msec) as previously reported.

Keywords: laser • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×